Sepsicure, L.L.C.: 药物管线_专利_临床试验_投融营收

概览

关联

1

项与 Sepsicure, L.L.C. 相关的药物

GR-270773

靶点

Endotoxin

作用机制

内毒素抑制剂

在研机构-

原研机构

Sepsicure, L.L.C.

在研适应症-

非在研适应症

疲劳 [+3]

最高研发阶段终止

首次获批国家/地区-

首次获批日期-

2

项与 Sepsicure, L.L.C. 相关的临床试验

NCT00506454 / Completed临床2期

A Phase II, Double-Blind, Placebo-Controlled, Randomized Study of the Effects of a Lipid Emulsion (Lipidose) on Endotoxin Levels in Patients on Chronic Hemodialysis

The purpose of this study is to determine whether a phospholipid emulsion is effective in the treatment of chronic endotoxemia in hemodialysis patients.

开始日期2007-08-01

申办/合作机构

Sepsicure, L.L.C.

[+1]

EUCTR2004-000406-51-AT / Not yet recruitingN/A

A Prospective, Randomized, Double-blind, Placebo Controlled, Dose Ranging, Multi-Center Study of the Safety and Efficacy of Three Days Continuous Intravenous Infusion of GR270773 in the Treatment of Suspected or Confirmed Gram-negative Severe Sepsis in Adults. - LIPOS

开始日期2004-11-23

申办/合作机构

Sepsicure, L.L.C.

100 项与 Sepsicure, L.L.C. 相关的临床结果

登录后查看更多信息

0 项与 Sepsicure, L.L.C. 相关的专利（医药）

登录后查看更多信息

100 项与 Sepsicure, L.L.C. 相关的药物交易

登录后查看更多信息